West Pharmaceutical Services (WST) Assets (2009 - 2026)

West Pharmaceutical Services has disclosed Assets across 18 years of filings, most recently posting $4.1 billion for Q2 2026.

• In Q2 2026, Assets rose 3.13% year-over-year to $4.1 billion; the TTM figure through Jun 2026 stood at $4.1 billion (up 3.13% YoY), while the FY2025 annual figure was $4.3 billion, up 17.2% from the prior year.
• Assets came in at $4.1 billion for Q2 2026 at West Pharmaceutical Services, down from $4.1 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $4.3 billion in Q4 2025 to a low of $3.3 billion in Q1 2022.
• Average Assets over 5 years is $3.7 billion, with a median of $3.7 billion recorded in 2023.
• Year-over-year, Assets advanced 20.26% in 2022 and slipped 4.91% in 2024.
• Over 5 years, Assets stood at $3.6 billion in 2022, then climbed by 5.88% to $3.8 billion in 2023, then slipped by 4.86% to $3.6 billion in 2024, then increased by 17.2% to $4.3 billion in 2025, then fell by 4.53% to $4.1 billion in 2026.
• Per Business Quant data, the three most recent Assets figures were $4.1 billion in Q2 2026, $4.1 billion in Q1 2026, and $4.3 billion in Q4 2025.